Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae
Clinical trial NCT05293873 · COMPLETED
Trial details
- NCT number
- NCT05293873
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-03-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.